Home
Home

M&A

Royalty Pharma eases condition for Elan offer

Royalty Pharma eases condition for Elan offer
Yahoo/AP

MannKind shares leap as web site says firm is a ripe takeover target

MannKind shares leap as web site says firm is a ripe takeover target
Marketwatch

Warner Chilcott CEO up for $9.2M handshake after Actavis deal

Warner Chilcott CEO up for $9.2M handshake after Actavis deal
Fierce Pharma

Royalty ups bid as Elan unveils acquisitions

Royalty ups bid as Elan unveils acquisitions
Pharma Times, UK

Three Reasons Actavis Is Buying Warner Chilcott

Three Reasons Actavis Is Buying Warner Chilcott
Forbes

Elan Makes Two Acquisitions for $380 Million

Elan Makes Two Acquisitions for $380 Million
Bloomberg

Actavis to buy Warner Chilcott in $8.5 bln deal

Actavis to buy Warner Chilcott in $8.5 bln deal
Reuters

Shire may return cash to thwart takeover, Daily Mail reports

Shire may return cash to thwart takeover, Daily Mail reports
Yahoo/Fly on the Wall

DEALTALK-Novartis' Vasella exit opens door to Roche stake sale

DEALTALK-Novartis' Vasella exit opens door to Roche stake sale
Reuters

Novartis says no intention of pursuing Actavis, Bloomberg reports

Novartis says no intention of pursuing Actavis, Bloomberg reports
Yahoo/Fly on the Wall